Biomind Labs Inc. (BMND.NE)

BRIEF

published on 11/21/2024 at 00:30, 1 month ago

Biomind Labs Sees Opportunity in U.S. Policy Shift for Psychedelic Therapies

FDA Approval Psychedelic Therapies Neurological Disorders BMND08 Drug U.S. Policy Shift
BRIEF

published on 11/21/2024 at 00:30, 1 month ago

Biomind Labs voit une opportunité dans le changement de politique américaine en matière de thérapies psychédéliques

Approbation De La FDA Troubles Neurologiques Thérapies Psychédéliques Médicament BMND08 Changement De Politique Aux États-Unis
PRESS RELEASE

published on 11/21/2024 at 00:25, 1 month ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies
Biomind Labs Inc., a leading biotech company, optimistic about U.S. government's stance on psychedelic industry. Company's BMND08 shows promising results in Phase II trial for neuropsychiatric disorders

FDA Neuropsychiatric Disorders Biomind Labs Inc. BMND08 Psychedelic Industry
BRIEF

published on 07/18/2024 at 14:35, 5 months 3 days ago

Biomind Labs Advances New Obesity Treatment with BMND06 Candidate Targeting Neurological Pathways

Obesity Treatment Clinical Trial Biomind Labs BMND06 Anti-inflammatory
BRIEF

published on 07/18/2024 at 14:35, 5 months 3 days ago

Biomind Labs fait progresser un nouveau traitement contre l'obésité avec le candidat BMND06 ciblant les voies neurologiques

Essai Clinique Traitement De L'obésité BMND06 Laboratoires Bioesprit Anti-inflammatoire
PRESS RELEASE

published on 07/18/2024 at 14:30, 5 months 3 days ago

Biomind Labs To Redefine Obesity Treatment With Its New BMND06 Candidate Targeting Neurological Pathways
Biomind Labs announced the decision to advance a Phase II clinical trial for BMND06, a novel compound with potential anti-inflammatory properties for treating obesity and neurological disorders

Phase II Trial Obesity Biomind Labs BMND06 Anti-inflammatory

Published on 12/21/2024 at 01:30, 14 hours 7 minutes ago

Quantum Biopharma Announces Closing of Second Tranche
Published on 12/21/2024 at 01:30, 14 hours 7 minutes ago

iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Published on 12/21/2024 at 00:05, 15 hours 32 minutes ago

Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Published on 12/21/2024 at 00:00, 15 hours 37 minutes ago

Amarc Announces Loan Extension
Published on 12/20/2024 at 23:30, 16 hours 7 minutes ago

Boron One Announces Extension to Early Warrant Exercise Incentive Program

View all ACCESSWIRE

Published on 12/21/2024 at 00:51, 14 hours 46 minutes ago

Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Published on 12/21/2024 at 00:45, 14 hours 52 minutes ago

EQS-Adhoc: PSI sells the Mobility business unit
Published on 12/20/2024 at 19:10, 20 hours 26 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 12/20/2024 at 18:56, 20 hours 41 minutes ago

CPI PROPERTY GROUP – Progress on Key Initiatives
Published on 12/20/2024 at 18:00, 21 hours 37 minutes ago

ARYZTA AG Announces New Board Technology Committee

View all EQS

Published on 12/21/2024 at 12:17, 3 hours 19 minutes ago

AXA annonce la signature d’un accord relatif à la vente d'AXA Investment Managers à BNP Paribas
Published on 12/21/2024 at 12:17, 3 hours 19 minutes ago

AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Published on 12/20/2024 at 18:00, 21 hours 37 minutes ago

Kapitaalverhoging door uitoefening van inschrijvingsrechten
Published on 12/20/2024 at 18:00, 21 hours 37 minutes ago

Capital increase through exercise of subscription rights
Published on 12/20/2024 at 17:55, 21 hours 42 minutes ago

Déclaration des transactions sur actions propres réalisées du 16/12/2024 au 20/12/2024

View all LES ECHOS COMFI WIRE

News